ArticleJournal of inflammation research2026
Bibliometric Analysis of Cow's Milk Protein Allergy Research in the Past Two Decades.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cow's Milk Protein Allergy (CMPA) is a prevalent food allergy in children with a rising global incidence. Despite extensive research, a comprehensive bibliometric analysis that links CMPA research trends to inflammation and immunological mechanisms is lacking. Methods: This study conducted a bibliometric analysis of CMPA-related literature from 2004 to 2024, utilizing the Web of Science database and tools such as Vosviewer, CiteSpace, and bibliometrix. The analysis explored publication trends, country/institution/author contributions, collaboration networks, journal impacts, high-frequency keywords, co-cited references, and citation bursts. Results: Recent years have seen significant growth in CMPA research, with publications peaking in 2022. Key contributors are the US, Italy, and China; Europe and America collaborate closely, while Asia, especially China, could enhance international cooperation. Leading authors like Vandenplas Y and Nowak-Wegrzyn A guide research and enjoy academic recognition. Core institutions, e.g. Icahn School of Medicine, have extensive networks. High-quality research appears in journals like Pediatric Allergy and Immunology, and Nutrients shows interdisciplinary trends. Hotspots include CMPA and oral immunotherapy (OIT). Foundational guidelines and reviews are key references. Citation bursts highlight research frontiers. Future research directions identified include immunotherapy, prevention strategies, and specific milk protein components, with OIT emerging as a key immunological intervention associated with immune tolerance induction. Conclusion: This analysis provides a comprehensive overview of CMPA research, emphasizing growth trends, hotspots, and future directions. By integrating bibliometric insights with immunological perspectives, it underscores the interplay between clinical management and mechanistic studies, particularly in the context of inflammation and immune regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.